- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07749222
Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes
Investigation Of Pulmonary Function, Respiratory Muscle Strength, Lung Age, Balance, And Quality Of Life In Paralympic Athletes: A Cross-Sectional Study
Paralympic athletes actively participate in many sports despite their physical limitations and continue to develop both individually and athletically. Assessing the physical and functional capacities of these athletes is important in terms of performance and health. This study aimed to examine the relationships between respiratory function, respiratory muscle strength, lung age, balance, and quality of life in Paralympic athletes. Additionally, it was evaluated whether there were significant differences in these parameters according to disability type and gender.
The study included 24 Paralympic athletes from the disciplines of athletics, swimming, archery, and wheelchair basketball. Participants had various orthopeadic and neurological disability types, including cerebral palsy, lower extremity amputation, spinal cord injuries (C5-T6 and T7 and below), hypotonia, poliomyelitis, spina bifida, brachial plexus injury, and short stature. Respiratory function was assessed using forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), FEV₁/FVC ratio, peak expiratory flow (PEF), and forced expiratory flow (FEF25-75%); respiratory muscle strength was assessed using maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP). Lung age was calculated based on FEV₁ values, balance was measured using the Modified Functional Reach Test, and quality of life was determined using the Short Form (SF-36) questionnaire. Significant correlations were found between parameters. Based on the study results, supporting respiratory muscle strength in Paralympic athletes may be an important goal in rehabilitation and training programs to support respiratory function, lung age, and quality of life parameters.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Istanbul, Turquía (Türkiye)
- İstanbul Okçular Vakfı
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Being between 18-50 years of age
- Being registered with any of the sports federations in Turkey and being a licensed paralympic athlete for at least 1 year (
- Having a lower extremity or upper extremity amputation or having permanent injuries as determined by the International Paralympic Committee
Exclusion Criteria:
- Lack of consent to participate in the study.
- Having undergone surgery within the last 6 months.
- Having had a respiratory tract infection within the three weeks prior to the evaluations
- FEV1/FVC < 0.7
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Forced expiratory volume in the first second (FEV1) (L)
Periodo de tiempo: 4 months
|
Pulmonary function (Forced expiratory volume in the first second FEV1)) was evaluated with a portable spirometer, COSMED Pony FX® (COSMED S.r.l., Italy) and measurements were performed according to European Respiratory Society standards. Considering that dizziness may occur during forced expiration, measurements were made while individuals were in a sitting position. While participants were sitting in a comfortable position in a chair with a backrest, nose clip was attached and they were asked to bite the mouth teeth and close their lips in a way that did not allow air to escape. The tests were performed at least 3 times by the participants and care was taken to ensure that the expiration time was at least 6 seconds and the plateau time was 1 second. Due to the device software that records all three data, it saved the average of the two best data and processed it as a value. |
4 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Forced vital capacity (FVC) (L)
Periodo de tiempo: 4 months
|
Pulmonary function ((Forced vital capacity (FVC )) was evaluated with a portable spirometer.
|
4 months
|
|
FEV1 / FVC (%)
Periodo de tiempo: 4 months
|
Pulmonary function (FEV1 / FVC) was evaluated with a spirometer.
|
4 months
|
|
Peak flow rate (PEF) (L/s)
Periodo de tiempo: 4 months
|
Pulmonary function (Peak flow rate (PEF)) was evaluated with a spirometer.
|
4 months
|
|
Flow rate 25-75% of forced expiratory volume (FEF 25-75%) (L/s)
Periodo de tiempo: 4 months
|
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) was evaluated with a spirometer.
|
4 months
|
|
Maximal expiratory pressure (MEP) (L)
Periodo de tiempo: 4 months
|
The MEP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
|
4 months
|
|
Maximal inspiratory pressure (MIP) (L)
Periodo de tiempo: 4 months
|
The MIP which shows respiratory muscle strength was evaluated using a portable mouth pressure measuring device based on European Respiratory Society criteria.
|
4 months
|
|
Balance
Periodo de tiempo: 4 months
|
Balance was measured using the Modified Functional Reach Test
|
4 months
|
|
Quality of Life
Periodo de tiempo: 4 months
|
Quality of life was determined using the Short Form-36 (SF-36) Health Survey that contains 36 questions and produces scores for eight health related quality of life domains.
Each domain is transformed to a 0-100 scale.
Higher scores represents better health status while lower stores represents poor health status.
|
4 months
|
|
Lung Age
Periodo de tiempo: 4 months
|
Lung age was calculated based on FEV₁ values.
For male: Lung age (years)=(2.87×height in cm×0.394)-(31.25×FEV1 in L)-39.375
For females: Lung age (years)=(3.56×height in cm×0.394)-(40×FEV1 in L)-77.280
|
4 months
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Morris JF, Temple W. Spirometric "lung age" estimation for motivating smoking cessation. Prev Med. 1985 Sep;14(5):655-62. doi: 10.1016/0091-7435(85)90085-4.
- Pinheiro L, Verhagen E, Ocarino J, Fagher K, Ahmed OH, Dalton K, Mann DL, Weiler R, Akinyi Okoth C, Blauwet CA, Lexell J, Derman W, Webborn N, Silva A, Resende R. Periodic health evaluation in Para athletes: a position statement based on expert consensus. BMJ Open Sport Exerc Med. 2024 Oct 9;10(4):e001946. doi: 10.1136/bmjsem-2024-001946. eCollection 2024.
- Freitas JP, Costa R, Barranco LC, Reis K, Lopes AJ, Mainenti MRM, Dos Santos Vigario P. Effect of inspiratory muscle training on pulmonary function, respiratory muscle strength, aerobic performance, sports skills, and quality of life in wheelchair rugby athletes. J Bodyw Mov Ther. 2024 Oct;40:360-365. doi: 10.1016/j.jbmt.2024.04.049. Epub 2024 Apr 20.
- Fischer G, Tarperi C, George K, Ardigo LP. An exploratory study of respiratory muscle endurance training in high lesion level paraplegic handbike athletes. Clin J Sport Med. 2014 Jan;24(1):69-75. doi: 10.1097/JSM.0000000000000003.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- Paralympic_Athlete
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .